Two monoanalytes, plasma chromogranin A (CgA) and urine 5-hydroxyindoleacetic acid (5HIAA) are used to monitor the course of these neoplasms during treatment of non-curable tumours, and may also have a role in detection of recurrence after potentially curative surgery or other treatments [1]. The gene discussed is CHGA; the disease is neoplasm.